Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: AIDS Care. 2020 Apr 26;32(8):1014–1022. doi: 10.1080/09540121.2020.1728213

Table 3.

Path coefficients

Paths β std.β 95% C.I. S.E. p-value
Medication adherence (continuous variable)
AS---»MS −0.264 −0.179 −0.241~−0.124 0.047 <0.001
MS---»ARTS 0.057 0.128 0.073~0.183 0.012 <0.001
AS---»ARTS −0.126 −0.194 −0.248~−0.138 0.018 <0.001
ARTS---»MED 0.026 0.166 0.107~0.230 0.005 <0.001
MS---»MED 0.001 0.014 −0.035~0.060 0.002 0.557
AS---»MED 0.003 0.026 −0.037~0.085 0.003 0.411
Medication adherence (dichotomized variable)
AS---»MS −0.265 −0.181 −0.357~−0.175 0.039 <0.001
MS---»ARTS 0.057 0.128 0.034~0.081 0.013 <0.001
AS---»ARTS −0.126 −0.194 −0.160~−0.088 0.020 <0.001
ARTS---»MED 0.043 0.216 0.027~0.059 0.008 <0.001
MS---»MED 0.001 0.017 −0.005~0.010 0.004 0.699
AS---»MED 0.005 0.035 −0.006~0.016 0.006 0.423

Note: AS: Anticipated stigma; MS: Medication support; ARTS: ART self-efficacy; MED: Medication adherence.